La Jolla Pharmaceutical Company announced the appointment of Darryl Wellinghoff as Chief Commercial Officer. Prior to joining the company, Mr. Wellinghoff spent 19 years in roles of increasing responsibility in the pharmaceutical industry including 15 years at The Medicines Company, where he was the Senior Vice President - Americas, leading the commercial organization through multiple hospital-based product launches in Cardiovascular, Surgical, and Infectious Disease. After a successful career at The Medicines Company, Mr. Wellinghoff was recruited to lead the build-out and launch of an innovative care model that addressed an unmet need in patients requiring inpatient care following a hospital stay. This experience allowed Mr. Wellinghoff to continue building deep relationships with healthcare leaders, physicians, and policy makers across the U.S. and deliver a much needed solution that benefited patients, providers and payors.